P

Inventor

JIANG HUALIANG

CN43 patents
⚠️ This page may combine multiple inventors who share the name “JIANG HUALIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SHANGHAI INST MATERIA MEDICA CAS

29 patents
US9637454B2May 2, 2017

Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereof

SHANGHAI INST MATERIA MEDICA CAS2 citations72
US9751882B2Sep 5, 2017

Diaryl[A, G]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereof

SHANGHAI INST MATERIA MEDICA CAS5 citations65
US12590061B2Mar 31, 2026

Crystalline form of acetylcholinesterase inhibitor and preparation method therefor and application thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations62
US10618900B2Apr 14, 2020

5-aromatic alkynyl substituted benzamide compound and preparation method, pharmaceutical composition, and use thereof

SHANGHAI INST MATERIA MEDICA CAS1 citations62
US11434226B2Sep 6, 2022

Salt and polymorph of benzopyrimidinone compound and pharmaceutical composition and use thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations60
US11384073B2Jul 12, 2022

Maleate salt of benzothiophene compound, crystalline form thereof, and use thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations59
US11013745B2May 25, 2021

Triazolopyrimidine, triazolopyridine compounds, and the composition thereof for treating PRC2-mediated diseases

SHANGHAI INST MATERIA MEDICA CAS1 citations59
US10966996B2Apr 6, 2021

Glechoma longitube extract, preparation method for same, and use thereof in sugar reduction, weight loss, and lipid reduction

SHANGHAI INST MATERIA MEDICA CAS0 citations59
US12351599B2Jul 8, 2025

Antiviral application of nucleoside analog or combination formulation containing nucleoside analog

SHANGHAI INST MATERIA MEDICA CAS1 citations58
US11919923B2Mar 5, 2024

Antiviral application of nucleoside analog or combination formulation containing nucleoside analog

SHANGHAI INST MATERIA MEDICA CAS1 citations56
US10640514B2May 5, 2020

Polymorph of DPPIV inhibitor maleate and preparation method therefor

SHANGHAI INST MATERIA MEDICA CAS0 citations51
US10611774B2Apr 7, 2020

Salt form of DPPIV inhibitor and preparation method thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations51
US12497394B2Dec 16, 2025

Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations50
US11731965B2Aug 22, 2023

Tetrahydroprotoberberine compound, preparation method therefor and uses thereof, and pharmaceutical composition

SHANGHAI INST MATERIA MEDICA CAS0 citations50
US10927107B2Feb 23, 2021

Phenyl [a]indole[2,3-g]quinolizine compounds, preparation method therefor, pharmaceutical composition, and applications thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations50
US10392401B2Aug 27, 2019

Crystal form A of compound and preparation method thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations50
US11873292B2Jan 16, 2024

Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations48
US12152017B2Nov 26, 2024

Ketoamide compound and preparation method, pharmaceutical composition, and use thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations47
US11427593B2Aug 30, 2022

Bromodomain inhibitor compound and use thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations47
US11142543B2Oct 12, 2021

Antidepressant compound and preparation method and application thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations44
US12145923B2Nov 19, 2024

Tetrahydroisoquinoline compound, preparation method therefor, pharmaceutical composition containing same, and use thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations42
US10550143B2Feb 4, 2020

C,O-spiro aryl glycoside compounds, preparation therefor and use thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations42
US12172989B2Dec 24, 2024

Histone acetyltransferase (HAT) inhibitor and use thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations41
US9737517B2Aug 22, 2017

Pharmaceutical use of hexahydro-dibenzo[a,g]quinolizine compounds

SHANGHAI INST MATERIA MEDICA CAS0 citations41
US10836743B2Nov 17, 2020

Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations39
US10800776B2Oct 13, 2020

Fluorine-containing triazolopyridine, and manufacturing method, pharmaceutical composition, and application thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations38
US10174011B2Jan 8, 2019

Heterocyclic compounds, process for preparation of the same and use thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations37
US10167299B2Jan 1, 2019

1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations36
US10875883B2Dec 29, 2020

Method for synthesizing novel chiral ligand, metal chelate, a variety of non-natural amino acids, maraviroc and key intermediate thereof

SHANGHAI INST MATERIA MEDICA CAS0 citations33

SHANGHAI INST MATERIA MEDICA

3 patents

WIGEN BIOMEDICINE TECH SHANGHAI CO LTD

3 patents

SHEN JIANHUA

2 patents

UNIV EAST CHINA SCIENCE & TECH

2 patents

SHANGHAI INST OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCE

1 patent

LIU ZHENG

1 patent

LI JIANFENG

1 patent

HU LIHONG

1 patent